# Pfizer Inc. – FDA 483, Sep 30, 2014

Source: https://www.keypedia.com/records/483/pfizer-inc/604fcf10-3f8c-4f4c-b790-320e59c6dd2a

> FDA 483 for Pfizer Inc. on September 30, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Pfizer Inc.
- Inspection Date: 2014-09-30
- Product Type: drugs
- Office Name: Division of Northeast Imports 
- Summary: An FDA inspection of Pfizer Inc. Groton Laboratories, a nonclinical laboratory, identified one observation. The observation noted that the study director failed to ensure that a protocol amendment for a toxicity study was approved and followed before the changes had already occurred. This indicates a procedural lapse in adhering to study protocols.

## Related Documents

- [483 - 2024-12-13](https://www.keypedia.com/records/483/pfizer-inc/0a8f268c-7a50-424d-b28d-4f771fa8db04) — date: December 13, 2024
- [EIR - 2021-01-08](https://www.keypedia.com/records/eir/pfizer-inc/629953a9-16fe-44af-88db-4dd1a6fe19f3) — date: January 8, 2021
- [EIR - 2018-11-02](https://www.keypedia.com/records/eir/pfizer-inc/142c3e7c-0df4-4b61-947a-8f0a135b254d) — date: November 2, 2018
- [EIR - 2018-07-18](https://www.keypedia.com/records/eir/pfizer-inc/c8390d3e-4400-4c07-aac0-d6309eb4b2d5) — date: July 18, 2018
- [EIR - 2018-06-21](https://www.keypedia.com/records/eir/pfizer-inc/b154586d-d538-42b1-a8ae-1deb0881329c) — date: June 21, 2018

## Related Officers

- [Matthew C. Watson](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/pfizer-inc/f8b3c75f-1ec4-46eb-97f9-f66bedfe6fe7

Office: https://www.keypedia.com/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94
